news Software developed by researchers accelerates analysis of lipids 29 April 2020 | By Victoria Rees (Drug Target Review) A novel software made by scientists can be used for the analysis of specific lipid groups and lipid signal molecules which can enable their characterisation with mass spectrometry.
news Relationships between SLCs and cytotoxic drugs in human cells uncovered 16 March 2020 | By Rachael Harper (Drug Target Review) A new systematic investigation on the role of solute carriers could lead to further insights into how the transporters affect the uptake and activity of drugs.
news European patent upheld for foundational CRISPR-Cas9 intellectual property 18 February 2020 | By Victoria Rees (Drug Target Review) Arguments filed in opposition to a patent for foundation CRISPR-Cas9 intellectual property have been broadly rejected by the European Patents Office.
news ‘Ubiquitin clipping’ proteomics technique could be used as novel treatment 14 August 2019 | By Victoria Rees (Drug Target Review) A new technique called ‘ubiquitin clipping’ has been created which could aid proteomics research and the development of new drugs for ubiquitination.
news Dispute over patent rights to CRISPR-Cas9 renewed by patent office 27 June 2019 | By Drug Target Review The patent office has declared an interference between 10 University of California (UC) patent applications.
news Targeting BAFF reduces the development of atherosclerosis 18 June 2018 | By Drug Target Review The researchers identified that BAFF to have anti-inflammatory properties, which has a positive effect on plaque size and atherosclerosis...
news Immune system can be modulated by targeted manipulation 21 August 2017 | By Dr Zara Kassam (Drug Target Review) Manipulation of the sugar metabolism and associated modulation of the immune system could open up new options for treating specific infectious and also autoimmune diseases...